Abstract
Economic and policy issues rein in industry enthusiasm for vaccines as an answer to drug-resistant bugs. Economic and policy issues rein in industry enthusiasm for vaccines as an answer to drug-resistant bugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have